Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Classen

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Immunology|May 25, 2016
The IgG1 B-cell receptor provides survival and proliferative signals analogue to the Igα but not the Igβ co-receptorJian Song, Nathalie Uyttersprot, Sabine Classen, et al.
Biomarkers in Medicine|May 19, 2010
Use of genome-wide high-throughput technologies in biomarker developmentSabine Classen, Andrea Staratschek-Jox, Joachim L Schultze
Expert Review of Molecular Diagnostics|April 22, 2009
Blood-based transcriptomics: leukemias and beyondAndrea Staratschek-Jox, Sabine Classen, Andrea Gaarz, et al.
Blood|January 18, 2006
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myelomaMarc Beyer, Matthias Kochanek, Thomas Giese, et al.
Clinical & Developmental Immunology|September 10, 2011
Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3Marc Beyer, Sabine Classen, Elmar Endl, et al.
Cancer Research|January 21, 2006
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphomaJens M Chemnitz, Julia Driesen, Sabine Classen, et al.
Plos One|January 26, 2012
In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administrationMarc Beyer, Beatrix Schumak, Martin R Weihrauch, et al.
Cancer Research|May 14, 2009
Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy"Marc Beyer, Julia Karbach, Michael R Mallmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1Luisa Klotz, Stephanie Hucke, Dominik Thimm, et al.
The Journal of Molecular Diagnostics : JMD|March 16, 2010
Bead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approachesAndrea Gaarz, Svenja Debey-Pascher, Sabine Classen, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Immunology|May 25, 2016
The IgG1 B-cell receptor provides survival and proliferative signals analogue to the Igα but not the Igβ co-receptorJian Song, Nathalie Uyttersprot, Sabine Classen, et al.
Biomarkers in Medicine|May 19, 2010
Use of genome-wide high-throughput technologies in biomarker developmentSabine Classen, Andrea Staratschek-Jox, Joachim L Schultze
Expert Review of Molecular Diagnostics|April 22, 2009
Blood-based transcriptomics: leukemias and beyondAndrea Staratschek-Jox, Sabine Classen, Andrea Gaarz, et al.
Blood|January 18, 2006
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myelomaMarc Beyer, Matthias Kochanek, Thomas Giese, et al.
Clinical & Developmental Immunology|September 10, 2011
Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3Marc Beyer, Sabine Classen, Elmar Endl, et al.
Cancer Research|January 21, 2006
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphomaJens M Chemnitz, Julia Driesen, Sabine Classen, et al.
Plos One|January 26, 2012
In vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administrationMarc Beyer, Beatrix Schumak, Martin R Weihrauch, et al.
Cancer Research|May 14, 2009
Cancer vaccine enhanced, non-tumor-reactive CD8(+) T cells exhibit a distinct molecular program associated with "division arrest anergy"Marc Beyer, Julia Karbach, Michael R Mallmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2009
Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1Luisa Klotz, Stephanie Hucke, Dominik Thimm, et al.
The Journal of Molecular Diagnostics : JMD|March 16, 2010
Bead array-based microrna expression profiling of peripheral blood and the impact of different RNA isolation approachesAndrea Gaarz, Svenja Debey-Pascher, Sabine Classen, et al.
Pageof 2